Home KOKA Life Sciences Appointed as Council Member of National Biopharma Enterprise Platform and Files IPO Prospectus

KOKA Life Sciences Appointed as Council Member of National Biopharma Enterprise Platform and Files IPO Prospectus

Dec 12, 2024 17:06 CST Updated 17:06
Kokai Life Sciences

Developer, Manufacturer, and Distributor in the Field of Structural Heart Disease